Teriparatide 20 microg daily in addition to standard care vs placebo + standard care
Healing of MRONJ · People with established (manifest) MRONJ
Teriparatide 20 microg daily in addition to standard care showed no clear difference in healing of MRONJ (resolution of lesions) compared with placebo in addition to standard care (low certainty).
1 finding from 1 review
- Interventions for managing medication‐related osteonecrosis of the jaw 2022 · Cochrane All outcomes52 weeksRR 0.96 [0.31, 2.95]1 study · 33 participantsLow